Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review

Objective: The objective of this study is to systematically review the economic evaluations of dapagliflozin in the treatment of patients with heart failure (HF) and describe their general and methodological features.Methods: This systematic review followed the PRISMA guidelines. MEDLINE/PubMed, Web...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Meiyu Wu, Shuxia Qin, Liting Wang, Chongqing Tan, Ye Peng, Xiaohui Zeng, Xia Luo, Lidan Yi, Xiaomin Wan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2022-04-01
Sarja:Frontiers in Pharmacology
Aiheet:
heart failure
dapagliflozin
cost-effectiveness analysis
systematic review
economic evaluation
Linkit:https://www.frontiersin.org/articles/10.3389/fphar.2022.860109/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia